Join us for an educational webinar focused on the evolving landscape of hepatocellular carcinoma (HCC) care, featuring a panel of esteemed experts in the field. This insightful event will explore the multifaceted aspects of HCC, from its etiologies and risk factors to the latest advancements in treatment options.

Our distinguished panelists, with their extensive clinical expertise, will provide a comprehensive overview of patient selection criteria, the current treatment landscape, and emerging therapies in HCC management. Attendees will gain valuable insights into the critical considerations for clinical trials and the implications of cutting-edge research on future treatment protocols.

This webinar is designed for healthcare professionals and industry experts interested in advancing their understanding of hepatocellular carcinoma care. Whether you are involved in patient care, clinical research, or the development of new therapies, this session will equip you with the knowledge to stay at the forefront of HCC treatment and improve patient outcomes. Don’t miss this opportunity to engage with leaders in the field and enhance your expertise in hepatocellular carcinoma management.

Panelists:

Josep Llovet, MD

Josep M. Llovet, MD, PhD is Director of the Liver Cancer Program and Professor of Medicine (Division of Liver Diseases) at the Icahn School of Medicine at Mount Sinai. He is also a Professor of Medicine-Hepatic Oncology at the University of Barcelona and a Professor of Research in the Liver Unit at IDIBAPS-Hospital Clínic of Barcelona.

Dr. Llovet was the Founder and has been President of the International Liver Cancer Association. He has chaired and contributed to the development of more than 10 guidelines related to clinical management and clinical trial design in liver cancer. He was Chairman of the European Association for the Study of Liver Disease (EASL)-Clinical Practice Guidelines 2012, President of the American Association for the Study of Liver Diseases Special Interest Group in Hepatobiliary Neoplasia, and a member of the Educational Committee of EASL. He has published more than 345 articles in peer-reviewed journals (with more than 145,000 citations) and more than 55 book chapters and has delivered more than 675 lectures. He is Editor in Chief of JHEP Reports and has been Associate/Senior Editor of the Journal of Hepatology and Clinical Cancer Research. Dr. Llovet has been a Top-1% cited researcher in Clarivate Analytics since 2014.

Dr. Llovet has devoted his career to studying the pathogenesis and treatment of liver cancer. He received the American Association for Cancer Research-Landon International Award (2009) and the International Hans Popper Award (2012), and has received competitive funding from the National Cancer Institute, the European Commission, and other grantors for more than 100 research projects.

Timothy Brown, MD

Timothy Brown, MD is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in the treatment of gastrointestinal cancers.

Dr. Brown earned his medical degree at the Penn State University College of Medicine and completed a residency in internal medicine at UT Southwestern, where he served as Chief Resident. He gained advanced training in hematology and oncology through a fellowship at the Hospital of the University of Pennsylvania, serving as Chief Fellow. He also earned a master’s degree in clinical epidemiology at the University of Pennsylvania.

Certified by the American Board of Internal Medicine, Dr. Brown joined the UT Southwestern faculty in 2023.

A prolific author and researcher, Dr. Brown has an interest in early-phase clinical trial design and outcomes research for gastrointestinal malignancies. He has published numerous articles in peer-reviewed journals and serves as an ad hoc reviewer for several journals, including Annals of Internal Medicine, Journal of Clinical Oncology, and Trends in Cancer.

He is an associate member of the American Association for Cancer Research and the American College of Physicians.

In 2023, Dr. Brown earned the Conquer Cancer Merit Award at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium.

Time: 10:00-11:00 am EST

Free!

Registration